WO2015080623A1 - Agent for the prevention of nausea and vomiting during pregnancy - Google Patents
Agent for the prevention of nausea and vomiting during pregnancy Download PDFInfo
- Publication number
- WO2015080623A1 WO2015080623A1 PCT/RU2014/000870 RU2014000870W WO2015080623A1 WO 2015080623 A1 WO2015080623 A1 WO 2015080623A1 RU 2014000870 W RU2014000870 W RU 2014000870W WO 2015080623 A1 WO2015080623 A1 WO 2015080623A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vitamin
- calcium
- magnesium stearate
- ginger
- folic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
Definitions
- the invention relates to the field of medicine and the food industry and relates to a method for producing tablet vitamin complexes that prevent nausea and vomiting.
- Vitamin complexes are used to fill the deficit of various nutrients in the body and in diseases associated with their deficiency.
- vitamins are especially important for expectant mothers.
- eating food that is rich in a variety of nutrients is not canceled. But taking vitamins helps compensate for the deficiency of their intake with food and can reduce the intensity of such unpleasant manifestations of an initial pregnancy as nausea and vomiting.
- Known source CN101283786 (A) - 2008-10-15 describing a food supplement to prevent motion sickness in the car and vomiting and the method for its preparation.
- the supplement includes orange peel, ginger and brown sugar.
- the production method includes the following steps: boiling raw materials, concentration and granulation.
- the prior art composition containing ginger powder, in combination with fillers, the process of its preparation, as well as its use for the treatment or prevention of nausea and / or vomiting and / or heartburn, ski acids, and / or reflux reflux, is beneficial for pregnant women , including as a food additive (WO2013110812 (A1) - 2013-08-01).
- the tool is made in the form of a gel. Not described is a method of producing tablets.
- ginger is an excellent remedy for nausea during pregnancy. But, despite the fact that quite a lot of medical studies have shown the effectiveness of ginger against nausea during pregnancy, it cannot be said that this is a universal remedy. In some women, ginger can exacerbate symptoms, provoke new problems, such as heartburn.
- KR20030008446 (A) - 2003-01-29 discloses a composition for the alleviation of nausea and vomiting of pregnant women (NVP).
- the described composition includes 60% or more by weight of ginger powder, 2 to 8% by weight of vitamin B6, 10 to 15% by weight of apricot powder and an additional 10 to 15% Chaenomeles sinensis powder by weight of the total weight of the composition.
- the composition does not contain important prenatal vitamins in sufficient quantities.
- B-Nexa® tablets are available that contain vitamins that are essential in nutrition and are designed to help soothe pregnant nausea and vomiting. Composition of tablets:
- the created tablets eliminate a number of disadvantages of the known complexes.
- allergic reactions have been reported when taking the tablets.
- the prior art does not disclose a method of obtaining these tablets, due to the significant content of auxiliary components, it is clear to a specialist that such a method is time-consuming.
- a method for producing a galenic form of ginger extract including tablets for the treatment of dyspeptic diseases, symptoms of motion sickness, as an antiemetic agent, as an antidiabetic agent, as an analgesic, and treatment of vomiting related to pregnancy or caused by chemotherapy, for the treatment of rheumatic diseases or as food additives (patent RU 2289420).
- a method of preparing a stable preparation of dry ginger extract includes extraction of crushed ginger roots to obtain a liquid extract solution, concentrating a liquid extract solution to obtain a viscous extract, diluting a viscous extract, adding a solution of polyvinylpyrrolidone as a stabilizing auxiliary agent with a certain ratio of auxiliary agent to natural extract, evaporation and drying.
- the ginger extract preparation thus obtained is compressed into a tablet coated with shell, with the addition of auxiliary substances, such as silicon dioxide, maltodextrins, magnesium stearate, cellulose or carboxymethyl starch.
- the objective of the invention is to develop a method for producing funds in the form of a vitamin complex, suitable for filling the deficiency of various nutrients in the body and for diseases associated with their deficiency, as well as to prevent nausea and vomiting.
- the resulting product contains a vitamin active complex, including folic acid, Vitamin B6, a pharmacologically acceptable source of calcium, ginger Zingiber officinalis in the form of a dry root extract, and excipients, including Sorbitol, Magnesium stearate, silicon dioxide in the following components in mg:
- Vitamin B6 20-50 mg
- This product is an effective, easy-to-use biologically active food supplement or vitamin supplement with a therapeutic and prophylactic effect.
- the tool is made in the form of a solid dosage form, such as granules, tablets, capsules.
- Usage oral, safe duration of admission at least 24 months.
- Ginger according to the present invention is used in the form of a well-known official dry extract (http://www.rlsnet.ru/prep index_id_340354.htm), which is obtained from crushed dried roots (rhizomes) of cultivated ginger Zingiber Officinale, the ginger family - Zingiberaceae, by water-alcohol extraction, followed by concentration and drying of the extract in vacuo -spray dryer. It is a brownish or brownish-yellow fine powder with a characteristic odor and specific taste.
- a well-known official dry extract http://www.rlsnet.ru/prep index_id_340354.htm
- It is a brownish or brownish-yellow fine powder with a characteristic odor and specific taste.
- the extract has anti-nausea and antiemetic, tonic, restorative, anti-aging, anti-platelet, analgesic, emollient, sedative, stimulating cell metabolism, anti-inflammatory, bactericidal, antimicrobial effects.
- Gingerols included in the composition improve digestion and metabolism.
- Folic acid refers to the water-soluble vitamins of group B. It is also known as folacin, or vitamin B9. Folic acid is essential for fetal development. It participates as a co-factor in a large number of important cellular reactions. Folic acid is a substrate for various biochemical reactions (such as transmethylation and transulfonation) associated with the metabolism of certain amino acids (series, glycine, methionine, histidine). During gestation, folate-dependent processes are the growth of the fetus, uterus, placenta and mammary glands, as well as an increase in the number of red blood cells. Thus, during pregnancy, the need for this vitamin increases dramatically.
- Vitamin B6 (pyridoxine) is required as a cofactor for amino acid metabolism enzymes, including enzymes, transaminating, deaminating and decarboxylating amino acids. Pyridoxine reduces the severity of nausea and vomiting.
- Pharmacologically acceptable sources of calcium may be calcium salts such as carbonate, calcium phosphate, calcium citrate, calcium gluconate, calcium lactate, etc., preferably dicalcium phosphate or tricalcium phosphate. Calcium is necessary for blood formation, metabolism, reduction of vascular permeability, for normal bone growth (skeleton, teeth); beneficial effect on the state of the nervous system, has an anti-inflammatory effect.
- the object of the present invention in addition to the optimized composition of the tool is a method for its preparation.
- the production method is characterized by the fact that folic acid, vitamin B6, a pharmacologically acceptable source of calcium, dry extract of ginger roots are mixed in dry form, mixed with a binder in the form of a solution containing sorbitol, silicon dioxide, magnesium stearate, the mixture is subjected to wet granulation, dried in a highly effective a fluidized bed dryer at a temperature of from 70 0 to 80 0 C for 7-10 minutes, then with hot air at a temperature in the range from 50 0 to 60 ° C, for 4 to 6 hours to a moisture content of 3-4%,
- the obtained dry granules are sieved, vibrated through sieves with sizes of 14-16 mesh, dusted with magnesium stearate and subjected to molding.
- composition of the vitamin complex per 1 tablet is the composition of the vitamin complex per 1 tablet:
- Sorbitol, silicon dioxide is sieved through 100 mesh sieves, magnesium stearate - 80 mesh sieves
- Particles larger than 100 mesh are screened and transferred to additional crushing.
- Folic acid, vitamin B6, calcium, ginger extract are mixed in dry form for 3-4 minutes. A binder is added and mixing lasts from 3 to 4 minutes.
- the resulting material has a soft consistency. It is granulated through a 14-16 mesh nylon sieve. Get the granules of the same size.
- a fluid bed dryer type "GFG-120” The vapor pressure is 0.2 to 0.3 MPa, with a transition to air pressure from 0.1 to 0.15 MPa. Drying with controlled temperature from 70 degrees to about 80 degrees for 7-10 minutes. Get the dried granules white-brown, uniform color, without foreign inclusions.
- Dusting dry granules and part of magnesium stearate are mixed for 20-30 minutes at a speed of 20 to 30 revolutions / min.
- Each bottle has a row of at least 60 tablets.
- Tablets obtained from the pharmaceutical composition of the present invention have acceptable physical characteristics, including optimal hardness, which provides resistance to rocks, abrasion during storage and transportation.
- the measurement was carried out by a standard test by weighing 20 tablets, placing them in a rotating plexiglass drum, in which they were lifted during repeated cycles using a circular lever (25 rpm) and dropped from a certain height. Spend about 100 cycles, the tablets are re-weighed and calculate the percentage of the composition, subjected to abrasion or chipping.
- the fragility of the tablets of the present invention is preferably in the range of from about 1-1.5%.
- the method is carried out as described in example 2, except that in the stage of molding granules with dusting substance is filled in hard gelatin capsules.
- the proposed tool can be used not only for pregnant women, but also as a vitamin remedy for debilitated patients, patients suffering from motion sickness in vehicles, etc.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Biophysics (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Средство для профилактики тошноты и рвоты при беременности Means for the prevention of nausea and vomiting during pregnancy
Изобретение относится к области медицины и пищевой промышленности и касается способа получения таблетированных витаминных комплексов, предупреждающих тошноту и рвоту. The invention relates to the field of medicine and the food industry and relates to a method for producing tablet vitamin complexes that prevent nausea and vomiting.
Витаминные комплексы служат для восполнения дефицита различных питательных веществ в организме и при заболеваниях, связанных с их недостатком. Vitamin complexes are used to fill the deficit of various nutrients in the body and in diseases associated with their deficiency.
Особенно важным является включение витаминов в рацион беременных женщин. Если в обычных витаминных комплексах содержатся определенные перечни витаминов, то в состав пренатальных витаминов, то есть витаминов, которые играют важную роль в организме беременных, как правило, включают фолиевую кислоту, кальций и железо. Эти компоненты особенно важны для будущих мам. При этом употребление пищи, которая богата разнообразными питательными веществами, не отменяется. Но прием витаминов помогает компенсации дефицита их поступления вместе с пищей и позволяет снизить интенсивность, таких неприятных проявлений начальной беременности как тошнота и рвота. Especially important is the inclusion of vitamins in the diet of pregnant women. If ordinary vitamin complexes contain certain lists of vitamins, then the composition of prenatal vitamins, that is, vitamins that play an important role in the body of pregnant women, as a rule, include folic acid, calcium and iron. These components are especially important for expectant mothers. At the same time, eating food that is rich in a variety of nutrients is not canceled. But taking vitamins helps compensate for the deficiency of their intake with food and can reduce the intensity of such unpleasant manifestations of an initial pregnancy as nausea and vomiting.
Известен способ получения состава для лечения тошноты и рвоты у онкологических больных в форме капсулы, содержащей имбирь и токоферол (US8435575 (В2)— 2013-05-07). Не описана возможность применения у беременных женщин. A known method of obtaining a composition for the treatment of nausea and vomiting in cancer patients in the form of a capsule containing ginger and tocopherol (US8435575 (B2) - 2013-05-07). The possibility of use in pregnant women is not described.
Известен источник CN101283786 (А)— 2008-10- 15, описывающий пищевую добавку для предотвращения укачивания в автомобиле и рвоты и способ его получения. Добавка включает апельсиновую корку, имбирь и коричневый сахар. Способ производства включает в себя следующие шаги: отваривание сырья, концентрирование и гранулирования. Из уровня техники известна композиция, содержащая порошок имбиря, в сочетании с наполнителями, процесс его подготовки, а также ее применение для лечения или предотвращения тошноты и/или рвоты и/или изжога, лыжный кислот, и/или рефлюкс рефлюксной, выгодно для беременных женщин, в том числе в качестве пищевой добавки (WO2013110812 (А1)— 2013-08-01). Средство выполнено в форме геля. Не описан способ получения таблеток. Known source CN101283786 (A) - 2008-10-15, describing a food supplement to prevent motion sickness in the car and vomiting and the method for its preparation. The supplement includes orange peel, ginger and brown sugar. The production method includes the following steps: boiling raw materials, concentration and granulation. The prior art composition containing ginger powder, in combination with fillers, the process of its preparation, as well as its use for the treatment or prevention of nausea and / or vomiting and / or heartburn, ski acids, and / or reflux reflux, is beneficial for pregnant women , including as a food additive (WO2013110812 (A1) - 2013-08-01). The tool is made in the form of a gel. Not described is a method of producing tablets.
Вышеперечисленные источники и многие другие раскрывают тот факт, что имбирь— прекрасное средство от тошноты во время беременности. Но, несмотря на то, что довольно много медицинских исследований показало эффективность имбиря от тошноты во время беременности, нельзя сказать, что это универсальное средство. У некоторых женщин имбирь может усилить симптомы, спровоцировать новые проблемы, такие как изжога. The above sources and many others reveal the fact that ginger is an excellent remedy for nausea during pregnancy. But, despite the fact that quite a lot of medical studies have shown the effectiveness of ginger against nausea during pregnancy, it cannot be said that this is a universal remedy. In some women, ginger can exacerbate symptoms, provoke new problems, such as heartburn.
KR20030008446 (А) — 2003-01-29 раскрывает композицию для облегчения тошноты и рвоты беременных (NVP). Описанная композиции включает в себя 60% или более по весу порошка имбиря, 2 до 8% от массы витамина В6, от 10 до 15% по весу порошка абрикосов и дополнительно от 10 до 15% Chaenomeles sinensis порошок по массе от общего веса состава. KR20030008446 (A) - 2003-01-29 discloses a composition for the alleviation of nausea and vomiting of pregnant women (NVP). The described composition includes 60% or more by weight of ginger powder, 2 to 8% by weight of vitamin B6, 10 to 15% by weight of apricot powder and an additional 10 to 15% Chaenomeles sinensis powder by weight of the total weight of the composition.
Композиция не содержит важных пренатальных витаминов в достаточном количестве. The composition does not contain important prenatal vitamins in sufficient quantities.
Выпускаются таблетки с коммерческим названием B-Nexa®, содержащие витамины, которые необходимы в питании и предназначены, чтобы помочь успокоить тошноту и рвоту беременных. Состав таблеток: Commercial name B-Nexa® tablets are available that contain vitamins that are essential in nutrition and are designed to help soothe pregnant nausea and vomiting. Composition of tablets:
Фолиевая Кислота 1,2 мг Folic Acid 1.2 mg
Кальций 124.1 мг Calcium 124.1 mg
Имбирь 100 мг Ginger 100 mg
Целлюлоза, Микрокристаллическая Cellulose, Microcrystalline
Мальтодекстрин Maltodextrin
Тальк Talc
Крахмал, Кукурузный Кроскармеллоза Натрия Corn starch Croscarmellose Sodium
Стеариновая Кислота Stearic Acid
Гипромеллоза Hypromellose
Диоксид Кремния Silica
Диоксид Титана Titanium dioxide
Гидроксипропилцеллюлоза Hydroxypropyl cellulose
Стеарат Магния Magnesium Stearate
Железа Оксид Желтый Iron Oxide Yellow
Железа Оксид Красный Iron Oxide Red
http://www.drugs.com/pro/b-nexa-tablets.html http://www.drugs.com/pro/b-nexa-tablets.html
Созданные таблетки устраняют ряд недостатков известных комплексов. Однако при приеме таблеток были зарегистрированы аллергические реакции. Хотя в уровне техники не раскрывается способ получения данных таблеток, ввиду значительного содержания вспомогательных компонентов, специалисту ясно, что такой способ является трудоемким. The created tablets eliminate a number of disadvantages of the known complexes. However, allergic reactions have been reported when taking the tablets. Although the prior art does not disclose a method of obtaining these tablets, due to the significant content of auxiliary components, it is clear to a specialist that such a method is time-consuming.
В качестве ближайшего аналога может быть указан способ получения галеновой формы экстракта имбиря, в том числе таблеток для лечения диспепсических заболеваний, симптомов морской болезни, в качестве противорвотного средства, в качестве противодиабетического агента, в качестве обезболивающего средства, лечения рвоты, связанной с беременностью или вызванной химиотерапией, для лечения заболеваний ревматического типа или в качестве пищевых добавок (патент RU 2289420). Способ приготовления стабильного препарата сухого экстракта имбиря, включает экстракцию измельченных корней имбиря с получением раствора жидкого экстракта, концентрирование раствора жидкого экстракта с получением вязкого экстракта, разведение вязкого экстракта, добавление раствора поливинилпирролидона в качестве стабилизирующего вспомогательного агента при определенном отношении вспомогательного агента к природному экстракту, упаривание и сушку. Полученный таким образом препарат экстракта имбиря прессуют в таблетку, покрытую з оболочкой, при добавлении вспомогательных веществ, таких как диоксиды кремния, мальтодекстрины, стеарат магния, целлюлозы или карбоксиметилкрахмалы. As the closest analogue, a method for producing a galenic form of ginger extract, including tablets for the treatment of dyspeptic diseases, symptoms of motion sickness, as an antiemetic agent, as an antidiabetic agent, as an analgesic, and treatment of vomiting related to pregnancy or caused by chemotherapy, for the treatment of rheumatic diseases or as food additives (patent RU 2289420). A method of preparing a stable preparation of dry ginger extract, includes extraction of crushed ginger roots to obtain a liquid extract solution, concentrating a liquid extract solution to obtain a viscous extract, diluting a viscous extract, adding a solution of polyvinylpyrrolidone as a stabilizing auxiliary agent with a certain ratio of auxiliary agent to natural extract, evaporation and drying. The ginger extract preparation thus obtained is compressed into a tablet coated with shell, with the addition of auxiliary substances, such as silicon dioxide, maltodextrins, magnesium stearate, cellulose or carboxymethyl starch.
Задачей изобретения является разработка способа получения средства в виде витаминного комплекса, пригодного для восполнения дефицита различных питательных веществ в организме и при заболеваниях, связанных с их недостатком, а также для предупреждения тошноты и рвоты. The objective of the invention is to develop a method for producing funds in the form of a vitamin complex, suitable for filling the deficiency of various nutrients in the body and for diseases associated with their deficiency, as well as to prevent nausea and vomiting.
Полученное средство содержит витаминный активный комплекс, включающий фолиевую кислоту, Витамин В6, фармакологически приемлемый источник кальция, имбирь Zingiber officinalis в виде сухого экстракта корней, и вспомогательные вещества, включающие Сорбит, Магния стеарат, диоксид кремния при следующем содержании компонентов в мг: The resulting product contains a vitamin active complex, including folic acid, Vitamin B6, a pharmacologically acceptable source of calcium, ginger Zingiber officinalis in the form of a dry root extract, and excipients, including Sorbitol, Magnesium stearate, silicon dioxide in the following components in mg:
Фолиевая кислота 0,7-1,5 мг Folic acid 0.7-1.5 mg
Витамин В6 20- 50 мг Vitamin B6 20-50 mg
Сухой экстракт корней имбиря 40-120 мг Dry extract of ginger roots 40-120 mg
Источник кальция Source of calcium
(в пересчете на элементарный кальций) 80-350 мг (in terms of elemental calcium) 80-350 mg
сорбит 1,5-2 мг sorbitol 1.5-2 mg
магния стеарат 100-120 мг magnesium stearate 100-120 mg
двуокись кремния 100-120 мг silicon dioxide 100-120 mg
Этот продукт представляет собой эффективную, простую в использовании биологически активную добавку к пище или витаминную добавку с лечебно-профилактическим эффектом. This product is an effective, easy-to-use biologically active food supplement or vitamin supplement with a therapeutic and prophylactic effect.
Средство выполнено в виде твердой лекарственной формы, такой как гранулы, таблетки, капсулы. The tool is made in the form of a solid dosage form, such as granules, tablets, capsules.
Использование: перорально, безопасная продолжительность приема по крайне мере 24 месяца. Usage: oral, safe duration of admission at least 24 months.
Имбирь, согласно настоящему изобретению, используют в виде известного официнального сухого экстракта (http://www.rlsnet.ru/prep index_id_340354.htm), который получают из измельченных высушенных корней (корневищ) культивируемого имбиря Zingiber Officinale, семейство имбирные - Zingiberaceae, методом водно- спиртовой экстракции, с последующим концентрированием и высушиванием экстракта на вакуумно-распылительной сушилке. Представляет собой коричневато- или буровато-желтый мелкодисперсный порошок с характерным запахом и специфическим вкусом. Ginger according to the present invention is used in the form of a well-known official dry extract (http://www.rlsnet.ru/prep index_id_340354.htm), which is obtained from crushed dried roots (rhizomes) of cultivated ginger Zingiber Officinale, the ginger family - Zingiberaceae, by water-alcohol extraction, followed by concentration and drying of the extract in vacuo -spray dryer. It is a brownish or brownish-yellow fine powder with a characteristic odor and specific taste.
Активные вещества: «гингерол», в состав которого входят смолы гингерол, цингерол, парадол, шогаол и др., с которыми связан жгучий имбирный вкус, а также сесквитерпены, углеводы, протеины, икроэлементы. Active substances: “gingerol”, which consists of gingerol, cingerol, paradol, shogaol and other resins, which have a burning ginger taste, as well as sesquiterpenes, carbohydrates, proteins, and trace elements.
Экстракт обладает противотошнотныи и противорвотным, тонизирующим, общеукрепляющим, омолаживающим, антитромбоцитарным, болеутоляющим, мягчительным, успокаивающим, стимулирующим клеточный метаболизм, противовоспалительным, бактерицидным, противомикробным действием. Входящие в состав гингеролы улучшают пищеварение и обмен веществ. The extract has anti-nausea and antiemetic, tonic, restorative, anti-aging, anti-platelet, analgesic, emollient, sedative, stimulating cell metabolism, anti-inflammatory, bactericidal, antimicrobial effects. Gingerols included in the composition improve digestion and metabolism.
Фолиевая кислота относится к водорастворимым витаминам группы В. Она также известна под названием фолацин, или витамин В9. Фолиевая кислота крайне необходима для развития плода. Она участвует в качестве ко- фактора в большом количестве важных клеточных реакций. Фолиевая кислота является субстратом для различных биохимических реакций (таких как трансметилирование и транссульфирование), связанных с метаболизмом некоторых аминокислот (серии, глицин, метионин, гистидин). На протяжении гестации фолат-зависимыми процессами являются рост плода, матки, плаценты и молочных желез, а также увеличение количества эритроцитов. Таким образом, во время беременности потребность в этом витамине резко возрастает. Folic acid refers to the water-soluble vitamins of group B. It is also known as folacin, or vitamin B9. Folic acid is essential for fetal development. It participates as a co-factor in a large number of important cellular reactions. Folic acid is a substrate for various biochemical reactions (such as transmethylation and transulfonation) associated with the metabolism of certain amino acids (series, glycine, methionine, histidine). During gestation, folate-dependent processes are the growth of the fetus, uterus, placenta and mammary glands, as well as an increase in the number of red blood cells. Thus, during pregnancy, the need for this vitamin increases dramatically.
Витамин В6 (пиридоксин) необходим в качестве кофактора для ферментов метаболизма аминокислот, в том числе для ферментов, трансаминирующих, дезаминирующих и декарбоксилирующих аминокислоты. Пиридоксин уменьшает выраженность тошноты и рвоты. Vitamin B6 (pyridoxine) is required as a cofactor for amino acid metabolism enzymes, including enzymes, transaminating, deaminating and decarboxylating amino acids. Pyridoxine reduces the severity of nausea and vomiting.
Фармакологически приемлемые источники кальция могут представлять собой соли кальция, такие как карбонат, фосфат кальция, цитрат кальция, глюконат кальция, лактат кальция и др., предпочтительно дикальция фосфат или трикальция фосфат. Кальций необходим для процессов кроветворения, обмена веществ, уменьшения проницаемости сосудов, для нормального роста костей (скелета, зубов); благотворно влияет на состояние нервной системы, оказывает противовоспалительное действие. Pharmacologically acceptable sources of calcium may be calcium salts such as carbonate, calcium phosphate, calcium citrate, calcium gluconate, calcium lactate, etc., preferably dicalcium phosphate or tricalcium phosphate. Calcium is necessary for blood formation, metabolism, reduction of vascular permeability, for normal bone growth (skeleton, teeth); beneficial effect on the state of the nervous system, has an anti-inflammatory effect.
Однако для того чтобы указанное активное начало витаминной добавки проявило все свои свойства, ее необходимо получить в удобной для приема форме. Это возможно при правильном выборе вспомогательных веществ. Кроме того, выбор и определенные режимы технологического процесса позволят придать таблетке необходимую твердость, улучшить механическую стабильность, достичь нужной растворимости, заданного времени высвобождения, оптимизировать биодоступность, решить проблемы с действующими веществами, чувствительными к влаге или температурному воздействию. Выбор вспомогательных веществ (или адьювантов) оказывает существенное влияние на фармакологическую активность готового лекарственного средства. Предметом настоящего изобретения помимо оптимизированного состава средства, является способ его получения. However, in order for the indicated active principle of the vitamin supplement to show all its properties, it must be obtained in a form convenient for administration. This is possible with the right choice of excipients. In addition, the choice and certain modes of the process will give the tablet the necessary hardness, improve mechanical stability, achieve the desired solubility, a predetermined release time, optimize bioavailability, solve problems with active substances that are sensitive to moisture or temperature effects. The choice of excipients (or adjuvants) has a significant effect on the pharmacological activity of the finished drug. The object of the present invention in addition to the optimized composition of the tool is a method for its preparation.
Способ получения характеризуются тем, что фолиевую кислоту, витамин В6, фармакологически приемлемый источник кальция, сухой экстракт корней имбиря смешивают в сухом виде, перемешивают с связующим в виде раствора, содержащего сорбит, диоксид кремния, стеарат магния, смесь подвергают влажному гранулированию, сушат в высокоэффективной сушилке кипящего слоя при температуре от 70 0 до 80 0 С в течение 7-10 минут, затем горячим воздухом при температуре в диапазоне от 50 0 до 60 °С, в течение 4 - 6 часов до содержания влаги 3-4%, The production method is characterized by the fact that folic acid, vitamin B6, a pharmacologically acceptable source of calcium, dry extract of ginger roots are mixed in dry form, mixed with a binder in the form of a solution containing sorbitol, silicon dioxide, magnesium stearate, the mixture is subjected to wet granulation, dried in a highly effective a fluidized bed dryer at a temperature of from 70 0 to 80 0 C for 7-10 minutes, then with hot air at a temperature in the range from 50 0 to 60 ° C, for 4 to 6 hours to a moisture content of 3-4%,
б полученные сухие гранулы просеивают, вибрируют через сита с размерами 14-16 меш, опудривают стеаратом магния и подвергают формованию. b the obtained dry granules are sieved, vibrated through sieves with sizes of 14-16 mesh, dusted with magnesium stearate and subjected to molding.
Изобретение может быть проиллюстрировано следующими примерами осуществления. The invention can be illustrated by the following embodiments.
Пример 1 Example 1
Состав витаминного комплекса на 1 таблетку: The composition of the vitamin complex per 1 tablet:
Фолиевая кислота 1,22 мг Folic Acid 1.22 mg
Витамин В6 42 мг Vitamin B6 42 mg
Сухой экстракт корней имбиря 100 мг Dry Ginger Root Extract 100 mg
Источник кальция Source of calcium
(в пересчете на элементарный кальций) 327 мг (in terms of elemental calcium) 327 mg
сорбит 1,78 мг sorbitol 1.78 mg
магния стеарат 114 мг magnesium stearate 114 mg
двуокись кремния 114 мг silicon dioxide 114 mg
Пример 2 Example 2
Способ приготовления таблеток витаминного комплекса (расчет на 100 штук) The method of preparation of tablets of the vitamin complex (calculation per 100 pieces)
1. Взвешивание, дозирование исходных материалов. 1. Weighing, dosing of raw materials.
Сорбит, диоксид кремния просеивают через сита 100 меш, стеарат магния - сита 80меш Sorbitol, silicon dioxide is sieved through 100 mesh sieves, magnesium stearate - 80 mesh sieves
При визуальном осмотре измельченного материала не должно быть никаких посторонних предметов, не должно наблюдаться изменения цвета During visual inspection of the crushed material there should not be any foreign objects, there should not be a color change
Частицы размером более 100 меш отсеивают и передают на дополнительное дробление. Particles larger than 100 mesh are screened and transferred to additional crushing.
2. Грануляция 2. Granulation
- Приготовление связующего - Cooking binder
Берут 0.178g Сорбита и 1 1.4g диоксида кремния и часть Магния стеарата и порошок используют для приготовления сиропа с водой. Нагревание при давлении пара 0,1 - 0.3 МПа. Полученный раствор связующего процеживают через сито 20 меш (mesh). - Процесс влажного гранулирования Take 0.178g of sorbitol and 1 1.4g of silicon dioxide and part of the magnesium stearate and powder are used to prepare a syrup with water. Heating at a vapor pressure of 0.1 - 0.3 MPa. The resulting binder solution is filtered through a 20 mesh sieve. - Wet granulation process
Фолиевую кислоту, витамин В6, кальций, экстракт имбиря смешивают в сухом виде 3 -4 минуты. Добавляют связующее и смешивание продолжается от 3 до 4 минут. Folic acid, vitamin B6, calcium, ginger extract are mixed in dry form for 3-4 minutes. A binder is added and mixing lasts from 3 to 4 minutes.
Полученный материал имеет мягкую консистенцию. Его гранулируют через нейлоновое сито 14 - 16 меш. Получают гранулы одинакового размера. The resulting material has a soft consistency. It is granulated through a 14-16 mesh nylon sieve. Get the granules of the same size.
3. Высушивание 3. Drying
- высокоэффективная сушка в сушилке кипящего слоя типа «GFG- 120». Давление пара составляет 0,2 0.3 Мпа, с переходом на давление воздуха от 0.1 до 0.15 Мпа. Сушка с контролируемой температурой от 70 градусов до около 80 градусов в течение 7-10 минут. Получают высушенные гранулы бело-коричневые, однородного цвета, без инородных включений. - high-efficiency drying in a fluid bed dryer type "GFG-120". The vapor pressure is 0.2 to 0.3 MPa, with a transition to air pressure from 0.1 to 0.15 MPa. Drying with controlled temperature from 70 degrees to about 80 degrees for 7-10 minutes. Get the dried granules white-brown, uniform color, without foreign inclusions.
- сушка горячим воздухом в термостате при температуре в диапазоне от 50 градусов до 60 °С, в течение 4 - 6 часов, в течение которых каждый час укладчик избежать агломерации частиц. Высушенные гранулы появление бело-коричневый, однородного цвета, без посторонних включений. Влага должна быть от 3% до 4%. - drying with hot air in a thermostat at a temperature in the range from 50 degrees to 60 ° C, for 4 to 6 hours, during which every hour the stacker avoids particle agglomeration. Dried granules appear white-brown, uniform in color, without foreign inclusions. Moisture should be between 3% and 4%.
4. Подготовка состава для формования 4. Preparation of the composition for molding
Вибрирование через сита 14 меш. Vibration through sieves 14 mesh.
Опудривание: сухие гранулы и часть стеарата магния перемешивают 20-30 минут при скорости от 20 до 30 оборотов/мин. Dusting: dry granules and part of magnesium stearate are mixed for 20-30 minutes at a speed of 20 to 30 revolutions / min.
5. Формование путем прессования таблеток 5. Molding by tablet compression
Осуществляют на роторной таблеточной машине ZP-19F Carried out on a rotary tablet machine ZP-19F
6. Упаковка 6. Packing
Используют пластиковые бутылки. Каждая бутылка имеет ряд не менее 60 таблеток. Use plastic bottles. Each bottle has a row of at least 60 tablets.
Пример 3 Example 3
Технологические характеристики Technological characteristics
Таблетки, полученные из фармацевтического состава по настоящему изобретению, обладают приемлемыми физическими характеристиками, включая оптимальную твердость, которая обеспечивает устойчивость к скалам, истиранию в условиях хранения и транспортировки. Tablets obtained from the pharmaceutical composition of the present invention have acceptable physical characteristics, including optimal hardness, which provides resistance to rocks, abrasion during storage and transportation.
Измерение проводили стандартным тестом путем взвешивания 20 таблеток, помещения их во вращающийся барабан из плексигласа, в котором их поднимают в ходе повторяющихся циклов при помощи кругового рычага (25 об./мин) и роняют с определенной высоты. Проводят около 100 циклов, таблетки повторно взвешивают и рассчитывают процент состава, подвергшегося истиранию или скалыванию. Хрупкость таблеток по настоящему изобретению предпочтительно находится в диапазоне приблизительно от 1-1,5%. The measurement was carried out by a standard test by weighing 20 tablets, placing them in a rotating plexiglass drum, in which they were lifted during repeated cycles using a circular lever (25 rpm) and dropped from a certain height. Spend about 100 cycles, the tablets are re-weighed and calculate the percentage of the composition, subjected to abrasion or chipping. The fragility of the tablets of the present invention is preferably in the range of from about 1-1.5%.
Пример 4 Капсулы Example 4 Capsules
Фолиевая кислота 0,7мг Folic Acid 0.7mg
Витамин В6 20мг Vitamin B6 20mg
Сухой экстракт корней имбиря 40мг Dry Ginger Root Extract 40mg
Источник кальция Source of calcium
(в пересчете на элементарный кальций) 200 мг (in terms of elemental calcium) 200 mg
сорбит 2 мг sorbitol 2 mg
магния стеарат 100 мг magnesium stearate 100 mg
двуокись кремния 100 мг silicon dioxide 100 mg
Пример 5 Способ получения капсул Example 5 Capsule Production Method
Способ осуществляют, как это описано в примере 2 за исключением того, что на стадии формования гранулами с опудривающим веществом заполняют твердые желатиновые капсулы. The method is carried out as described in example 2, except that in the stage of molding granules with dusting substance is filled in hard gelatin capsules.
Испытания на добровольцах показали прекрасную переносимость и значительное улучшение самочувствия при тошноте, устранение рвотных рефлексов. Tests on volunteers showed excellent tolerance and a significant improvement in well-being with nausea, the elimination of vomiting reflexes.
Предложенное средство может быть использовано не только для беременных женщин, но и в качестве витаминного средства для ослабленных больных, пациентов, страдающих от укачивания в транспорте и т.п. The proposed tool can be used not only for pregnant women, but also as a vitamin remedy for debilitated patients, patients suffering from motion sickness in vehicles, etc.
Claims
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2013152386/15A RU2540508C1 (en) | 2013-11-26 | 2013-11-26 | Agent for prevention of nausea and vomiting of pregnancy |
| RU2013152386 | 2013-11-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2015080623A1 true WO2015080623A1 (en) | 2015-06-04 |
Family
ID=53199441
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/RU2014/000870 Ceased WO2015080623A1 (en) | 2013-11-26 | 2014-11-17 | Agent for the prevention of nausea and vomiting during pregnancy |
Country Status (2)
| Country | Link |
|---|---|
| RU (1) | RU2540508C1 (en) |
| WO (1) | WO2015080623A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020118089A1 (en) * | 2018-12-08 | 2020-06-11 | Aphios Corportion | Methods and products for treating folic acid deficiency and morning sickness |
| WO2023031779A1 (en) * | 2021-09-03 | 2023-03-09 | PATEL, Natvarlal Hargovinddas | Compositions, kits, and methods to provide synergistic and/or additive effects from comprised ingredients for the prevention, treatment and management of nausea and vomiting |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2134045C1 (en) * | 1998-01-08 | 1999-08-10 | Открытое акционерное общество "Владивостокская фармацевтическая фабрика" | Method of preparing biologically active food additive and biologically active food additive "elevita" (versions) |
| RU2289420C2 (en) * | 2001-11-26 | 2006-12-20 | Финцельберг Гмбх Унд Ко. Кг | Ginger extract-based preparation |
| US8435575B2 (en) * | 2010-05-13 | 2013-05-07 | Aphios Corporation | Use of gingerols for cancer patients suffering from nausea and emesis induced by chemotherapy |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2986136B1 (en) * | 2012-01-27 | 2016-10-07 | Denali Pharma | COMPOSITION IN THE FORM OF A GELULE COMPRISING GINGER POWDER AND A COATING AGENT |
-
2013
- 2013-11-26 RU RU2013152386/15A patent/RU2540508C1/en active
-
2014
- 2014-11-17 WO PCT/RU2014/000870 patent/WO2015080623A1/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2134045C1 (en) * | 1998-01-08 | 1999-08-10 | Открытое акционерное общество "Владивостокская фармацевтическая фабрика" | Method of preparing biologically active food additive and biologically active food additive "elevita" (versions) |
| RU2289420C2 (en) * | 2001-11-26 | 2006-12-20 | Финцельберг Гмбх Унд Ко. Кг | Ginger extract-based preparation |
| US8435575B2 (en) * | 2010-05-13 | 2013-05-07 | Aphios Corporation | Use of gingerols for cancer patients suffering from nausea and emesis induced by chemotherapy |
Non-Patent Citations (3)
| Title |
|---|
| "Meditsina", TEKHNOLOGIYA LEKARSTVENNYKH FORM, M., vol. 2, 1991, pages 142 - 165 * |
| B-NEXA TABLETS. DRUGS.COM, pages 1 - 6, Retrieved from the Internet <URL:http://www.drugs.com/pro/b-nexa-tablets.html> [retrieved on 20150127] * |
| CHUESHOV V.I. ET AL.: "Promyshlennaya tekhnologiya lekarstv, Kharkov", IZDATELSTVO NFAU MTK-KNIGA, vol. 2, 2002, pages 331 - 332 * |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2020118089A1 (en) * | 2018-12-08 | 2020-06-11 | Aphios Corportion | Methods and products for treating folic acid deficiency and morning sickness |
| CN113645973A (en) * | 2018-12-08 | 2021-11-12 | 阿菲欧斯公司 | Methods and products for treating folate deficiency and early pregnancy response |
| US20220016120A1 (en) * | 2018-12-08 | 2022-01-20 | Aphios Corporation | Methods and products for treating folic acid deficiency and morning sickness |
| JP2022512331A (en) * | 2018-12-08 | 2022-02-03 | アフィオス コーポレーション | Methods and products for treating folic acid deficiency and morning sickness |
| EP3890739A4 (en) * | 2018-12-08 | 2022-10-26 | Aphios Corporation | Methods and products for treating folic acid deficiency and morning sickness |
| JP7520838B2 (en) | 2018-12-08 | 2024-07-23 | アフィオス コーポレーション | Methods and Products for Treating Folic Acid Deficiency and Morning Sickness - Patent application |
| WO2023031779A1 (en) * | 2021-09-03 | 2023-03-09 | PATEL, Natvarlal Hargovinddas | Compositions, kits, and methods to provide synergistic and/or additive effects from comprised ingredients for the prevention, treatment and management of nausea and vomiting |
Also Published As
| Publication number | Publication date |
|---|---|
| RU2540508C1 (en) | 2015-02-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7574351B2 (en) | Capsule and powder formulations containing lanthanum compounds | |
| TWI410258B (en) | Improved stability in vitamin and mineral supplements | |
| HRP20000434A2 (en) | Celecoxib compositions | |
| MXPA02005486A (en) | Nutritional composition. | |
| CN105363023A (en) | Composition with effects of protecting joints and increasing bone mineral density and preparation method of composition | |
| RU2540508C1 (en) | Agent for prevention of nausea and vomiting of pregnancy | |
| CN1927383B (en) | Compound preparation for rapidly reducing oxidative stress and preparation method thereof | |
| CZ303069B6 (en) | Therapeutical preparation containing calcium or a mixture of calcium and vitamin D or a mixture of calcium and magnesium in a novel medicament formulation | |
| CN101716180A (en) | Combined medicament for supplementing zinc and calcium and preparation method thereof | |
| KR102772003B1 (en) | Method for preparing easy-to-take tablets containing dried extract of bank leaves | |
| CN105581331B (en) | Calcium supplement nutritional composition | |
| WO2016086557A1 (en) | Vitamin d calcium composition chewing tablet and preparation method thereof | |
| CN104126806B (en) | Vitamin B12sublingual lozenge and preparation method thereof | |
| CN101176734A (en) | Nutrients replenisher for replenishing folic acid and vitamin B12 and preparation method thereof | |
| WO2015001329A1 (en) | Chewable tablet | |
| CN115721614B (en) | A kind of α-KG sustained-release preparation and use | |
| WO2005084703A1 (en) | Sustained-release composition for oral cavity | |
| KR20100056329A (en) | Calcium compound and calcium compound fertilized rice for the prevention and treatment of osteoporosis | |
| CN102000110A (en) | A composition for preventing or treating bone and joint diseases and its preparation method | |
| KR101169931B1 (en) | Health supplement comprising wild―peach powder as a staple ingredient and the manufacturing method thereof | |
| KR20170012169A (en) | Complex preparation for oral use | |
| CN104127435A (en) | Vitamin mineral sublingual lozenge and a preparation method thereof | |
| CN103316021B (en) | The pharmaceutical composition of a kind of calcitriol and calcic thing composition and purposes | |
| JP7505831B2 (en) | Hypertension improving agent containing seaweed extract, and functional foods, quasi-drugs and medicines containing said hypertension improving agent | |
| CN115177732B (en) | Composition for assisting in preventing and relieving gout |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 14865807 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 14865807 Country of ref document: EP Kind code of ref document: A1 |